Coronary Artery Disease and Heart Failure-Continued Significant Morbidity and Mortality Highlights Need for Comprehensive Evaluation to Individualize Patient Management [0.03%]
冠状动脉疾病和心力衰竭 - 持续显著的发病率和死亡率突出需要进行全面评估以实现患者管理的个体化
Jyothy J Puthumana,Ragavendra R Baliga,Eduardo Bossone
Jyothy J Puthumana
Yash Kamani,Graham Peigh,Nishant Verma et al.
Yash Kamani et al.
This review discusses the range of device therapy for ischemic cardiomyopathy (ICM). This article will review the primary data supporting guideline indications for cardiac implantable electronic devices in patients with ICM, with a focus on...
Abhinav Sehgal,Graham Peigh,Jeremiah Wasserlauf et al.
Abhinav Sehgal et al.
Atrial and ventricular arrhythmias are highly comorbid with ischemic cardiomyopathy (ICM) and are associated with worsening symptoms, morbidity, and mortality. This review will discuss the pathophysiology, evaluation, and treatment of each ...
Rashmi Nedadur,Melissa Medina,Miia Lehtinen et al.
Rashmi Nedadur et al.
Coronary artery bypass grafting is the major modality of coronary revascularization in patients with ischemic cardiomyopathy as it provides surgical collateralization of the coronary bed protecting the functional myocardium. Myocardial viab...
Percutaneous Coronary Intervention for Heart Failure due to Coronary Artery Disease [0.03%]
经皮冠状动脉介入治疗冠状动脉疾病引起的心力衰竭
Arushi Singh,Robert S Zhang,Sripal Bangalore
Arushi Singh
The role of revascularization and percutaneous coronary intervention (PCI) in patients with acute coronary syndrome is well established. However, the incremental value of revascularization over guideline-directed medical therapy is controve...
Obesity Management for Patients with Coronary Artery Disease and Heart Failure [0.03%]
冠状动脉疾病和心力衰竭患者的肥胖管理
Akheel A Syed,Safwaan Adam,Christopher A Miller et al.
Akheel A Syed et al.
Obesity is causally linked to heart disease directly by triggering various adverse pathophysiological changes and indirectly through convergent risk factors such as type 2 diabetes, hypertension, dyslipidemia, and sleep disorder. Weight red...
Coronary Artery Disease and Heart Failure: Medical Management and Future Direction [0.03%]
冠状动脉疾病和心力衰竭：药物治疗及未来趋势
Prem N Patel,Michael C Poliner,Eduardo Bossone et al.
Prem N Patel et al.
Coronary artery disease (CAD) is a leading etiology of heart failure (HF) and serves as a significant therapeutic target to ameliorate HF-associated morbidity and mortality. Key management considerations include pharmacologic treatment, ele...
Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus [0.03%]
人类免疫缺陷病毒患者中心脏缺血疾病中的免疫失调现象
Meilynn Shi,Matthew J Feinstein
Meilynn Shi
Individuals with human immunodeficiency virus (HIV) experience an elevated risk of ischemic heart disease and related cardiovascular sequelae. This is due to a combination of factors including traditional comorbidities, adverse effects of a...
Mehmet Onur Omaygenc,Lisa Marie Mielniczuk
Mehmet Onur Omaygenc
Management of ischemic cardiomyopathy is challenging, especially when treatment benefits do not clearly exceed the estimated risk of procedures. Myocardial viability assessment provides additional data in this setting to anticipate potentia...
Coronary Microvascular Dysfunction: Identification, Special Populations, and Management Strategies [0.03%]
冠状动脉微血管功能障碍：识别，特殊人群和管理策略
Marcelo F Di Carli
Marcelo F Di Carli
Coronary microvascular dysfunction (CMD) is a prevalent and often underdiagnosed condition with significant implications for adverse cardiovascular outcomes. The pathophysiology of CMD includes structural and functional abnormalities in the...